ArticleNursing in critical care2026
Anxiety and Depression Symptoms in ICU Survivors After COVID-19.
Article in Nursing in critical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPost-intensive care syndrome includes physical, cognitive and psychological impairments that may persist after discharge from the intensive care unit (ICU), with anxiety and depression among the most commonly reported symptoms. Evidence on these symptoms beyond the first year after discharge remains limited, particularly in patients admitted for COVID-19.
aimTo determine the prevalence and characteristics of anxiety and depression symptoms among patients previously admitted to the ICU for COVID-19 within three years after discharge, and to examine differences according to sociodemographic and clinical variables. STUDY
designA multicentre, descriptive cross-sectional study was conducted among ICU survivors in Spain using clinical records and structured telephone interviews. Sociodemographic, clinical and patient-reported outcomes were obtained. The Hospital Anxiety and Depression Scale (HADS) was used to assess symptoms of anxiety (HADS-A) and depression (HADS-D).
resultsA total of 106 participants were included. Mean anxiety (HADS-A) and depression (HADS-D) scores were 6.5 (SD ±3.9) and 6.7 (SD ±3.8), respectively. Female sex was linked to higher anxiety (β = 1.73; 95% CI, 0.32-3.13; p = 0.016), while memory problems were associated with higher anxiety (β = 1.49; 95% CI, 0.14-2.83; p = 0.031) and depression (β = 1.65; 95% CI, 0.43-2.86; p = 0.009). Depression was also higher in participants with greater pain (β = 0.50; 95% CI, 0.15-0.84; p = 0.006). Higher quality of life (β = -0.07; 95% CI, -0.11 to -0.03; p < 0.001) was associated with lower depression scores.
conclusionsAnxiety and depression were common among individuals with a history of ICU admission due to COVID-19 up to three years after discharge. Psychological symptoms should be considered alongside physical and cognitive aspects. RELEVANCE TO CLINICAL PRACTICE: Incorporating psychological assessment into the long-term follow-up may facilitate identifying individuals who may benefit from further support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.